Eton Pharmaceuticals: Strong Financial Performance and Growth Prospects Drive Buy Rating
Swayampakula Ramakanth, an analyst from H.C. Wainwright, maintained the Buy rating on Eton Pharmaceuticals (ETON – Research Report). The ...
Promising Growth Ahead: Xenon’s Strategic Pipeline Advancements and Buy Rating
Xenon (XENE – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Mohit Bansal ...
Value or Growth? Large or Small Cap? Which Stocks Outperform in the First Year of a Presidential Term?
With a new president slated to take office next year, will tech and growth stocks continue their impressive run, or is a new group poised to outperform?